FORT MILL, S.C., March 26, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the ...
Odor Solution™ will be launched in Q2 2025FDA clearance and MDR certification already securedFirst generation hygh-tec™ catheter rapidly ...
SmartfIRE 12-month data demonstrated 86.9% effectiveness when utilized with high adherence to the recommended ablation workflow and significant quality of life improvements using the Dual Energy ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
WOODTV.com on MSN6d
Medical device manufacturer to pay $550K to settle lawsuitA medical device manufacturer and its owner have agreed to pay $550,000 to settle a lawsuit alleging that they told health ...
Stereotaxis has announced the submission of the MAGiC Sweep™ catheter for FDA approval ... to leverage its technology to improve patient care and expand access to minimally invasive therapies.
ASAHI INTECC USA, Inc. is pleased to announce the newest addition to its product portfolio through a distribution partnership with Medikit of Super Sheath™ Introducer Sheath. This collaboration will ...
EMAGIN 5F is a catheter guide with a 5-French diameter ... Stereotaxis a multi-specialty robotics leader advancing clinical care in interventional cardiology, radiology and neurology.
NanoVibronix, Inc. (the "Company" or "NanoVibronix"), a medical technology company specializing in non-invasive therapeutic devices, today announced the renewal and expansion of its exclusive ...
Stereotaxis, a leader in surgical robotics, has announced the FDA submission for its first robotically navigated catheter ... leader advancing clinical care in interventional cardiology, radiology ...
Corient Private Wealth LLC lessened its position in shares of ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 61.6% during ...
The pressure to improve outcomes may convince nursing homes to tap into new clinical resources, but not every pitch is worth the investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback